Clinical Trial Update: Efficacy and Safety of Mometasone Furoate for Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids (ICS) (Study P06115) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating mometasone furoate for persistent asthma in patients previously treated with low-dose inhaled corticosteroids was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mometasone furoate (Mometasone furoate)

Snippet

Sponsor: Organon and Co | Conditions: Asthma | Phase 3 | Status: WITHDRAWN